BNKL (Bionik Laboratories) OCF Margin %: -151.10% (As of Mar. 2023)


BNKL Bionik Laboratories Corp BNKL
12 GF Score
Price $0.00
View Full Analysis

What is Bionik Laboratories OCF Margin %?

Bionik Laboratories BNKL -99.00% 12 OCF Margin % is -151.10% as of Mar. 2023. GuruFocus rates BNKL with a GF Score™ of 12/100.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Bionik Laboratories's Cash Flow from Operations for the three months ended in Mar. 2023 was $-0.76 Mil. Bionik Laboratories's Revenue for the three months ended in Mar. 2023 was $0.50 Mil. Therefore, Bionik Laboratories's OCF Margin % for the quarter that ended in Mar. 2023 was -151.10%.

As of today, Bionik Laboratories's current OCF Yield % is 0.00%.

The historical rank and industry rank for Bionik Laboratories's OCF Margin % or its related term are showing as below:

BNKL' s OCF Margin % Range Over the Past 10 Years
Min: 0   Med: 0   Max: 0
Current: -187.65

BNKL's OCF Margin % is not ranked
in the Healthcare Providers & Services industry.
Industry Median: 8.27 vs BNKL: -187.65

Bionik Laboratories OCF Margin % Related Terms

Bionik Laboratories OCF Margin % Historical Data

* Premium members only.

The historical data trend for Bionik Laboratories's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bionik Laboratories OCF Margin % Chart

Bionik Laboratories Annual Data
Trend Dec14 Dec15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -284.41 -420.99 -387.59 -325.51 -187.65

Bionik Laboratories Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -722.51 -478.19 -196.50 -89.22 -151.10

BNKL vs ARPC, GRST, IONM: OCF Margin % Comparison

For the Medical Care Facilities subindustry, Bionik Laboratories's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bionik Laboratories OCF Margin % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Bionik Laboratories's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Bionik Laboratories's OCF Margin % falls into.


BNKL
12GF Score
Bionik Laboratories Corp BNKL
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bionik Laboratories OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Bionik Laboratories's OCF Margin for the fiscal year that ended in Mar. 2023 is calculated as

OCF Margin=Cash Flow from Operations (A: Mar. 2023 )/Revenue (A: Mar. 2023 )
=-3.387/1.805
=-187.65 %

Bionik Laboratories's OCF Margin for the quarter that ended in Mar. 2023 is calculated as

OCF Margin=Cash Flow from Operations (Q: Mar. 2023 )/Revenue (Q: Mar. 2023 )
=-0.757/0.501
=-151.10 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of -151.10% mean?
Bionik Laboratories (BNKL) has a OCF Margin % of -151.10% as of Mar. 2023. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Bionik Laboratories and its competitors.
Is Bionik Laboratories' OCF Margin % too high?
Bionik Laboratories' current OCF Margin % is -151.10%. Overall, Bionik Laboratories has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Bionik Laboratories' OCF Margin % compare to ARPC and GRST?
Bionik Laboratories' OCF Margin % of -151.10% can be compared against companies in the Healthcare Providers & Services industry. The industry median OCF Margin % is 8.27. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Healthcare Providers & Services company?
The median OCF Margin % among Healthcare Providers & Services companies is 8.27, based on 666 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Bionik Laboratories and its competitors. For the Healthcare Providers & Services industry, the median OCF Margin % is 8.27 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bionik Laboratories's current OCF Margin % is -151.10%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bionik Laboratories stock overvalued right now?
Bionik Laboratories (BNKL) has a current OCF Margin % of -151.10%. The current OCF Margin % is -151.10%. Bionik Laboratories' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Bionik Laboratories (BNKL), the current OCF Margin % is -151.10% as of Mar. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bionik Laboratories Business Description

Address 80 Coolidge Hill Road, Watertown, MA, USA, 02472
Bionik Laboratories Corp is a healthcare company focused on improving the quality of life of millions of people with neurological or mobility impairments by combining artificial intelligence and robotics technology to help individuals from hospital to home regain mobility, enhance autonomy, and regain self-esteem. The company uses artificial intelligence and machine learning technologies to make rehabilitation methods and processes smarter and more intuitive to deliver a greater recovery for patients with neurological or mobility impairments. Its products The InMotion ARM, and InMotion ARM/HAND are robotic therapies for the upper limbs.
12GF Score

Get the complete analysis for BNKL

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price